Most People Already Have Immune Defenses Against H5N1 Bird Flu: Journal 'Immunity'
94% had H5 antibodies, 100% showed neutralization despite no exposure to virus.
A new peer-reviewed study published last week in the journal Immunity reports that the vast majority of people already carry antibodies capable of neutralizing the cattle-linked purported H5N1 bird flu virus, despite having no known exposure to H5N1 and being classified as immunologically naïve.
The findings challenge the widespread assumption that humans are broadly unprotected against H5N1—an assumption that has underpinned recent pandemic warnings tied to the virus’s spread in U.S. dairy cattle.
It also challenges the justification for government-led gain-of-function bird flu experiments and mass vaccine development programs built on the premise that humans have little to no existing immunity, including the Trump administration’s $500 million “next-generation, gold-standard” bird flu vaccine effort.
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities reaching 300,000+ monthly viewers, contact us by clicking below.
Study Finds Antibodies in Nearly All Unexposed Individuals
Researchers analyzed blood samples from 66 individuals in Germany with no known exposure to H5N1.
Using multiple laboratory tests, the study found that 94% had detectable IgG antibodies that bind to the H5 hemagglutinin protein, while 100% showed measurable neutralizing activity against the cattle-associated H5N1 strain A/Texas/37/2024 in a sensitive neutralization system.
As the authors state in the paper:
“The majority of investigated H5N1-naïve individuals harbor detectable H5-reactive antibodies.”
In another section, the researchers emphasize the universality of the finding:
“We detected low but distinct cross-neutralizing titers against A/Texas/37/2024 in all study participants.”
The study reports that antibody levels against H5N1 were lower than those typically seen for common seasonal influenza strains such as H1N1 and H3N2, but consistently present across the cohort.
Who Conducted the Research
The study was conducted by researchers from multiple major European institutions, including the University of Cologne, the Friedrich-Loeffler-Institut—Germany’s federal research institute for animal health—and the German Center for Infection Research.
The Friedrich-Loeffler-Institut, in particular, plays a central role in high-containment animal disease research in Germany, including work on avian influenza.
Immune Memory Cells Encode Potent H5-Neutralizing Antibodies
Beyond blood serum testing, the researchers isolated memory B cells from selected participants and cloned 136 monoclonal antibodies for further analysis.
They found that five out of six individuals classified as H5N1-naïve carried memory B cells that produced antibodies capable of neutralizing H5N1.
Most of these antibodies were also cross-reactive with H1 influenza strains and primarily targeted the conserved hemagglutinin stem, rather than the highly variable head region.
More than 60% of the H5-neutralizing antibodies used the IGHV1-69 gene segment, a genetic feature commonly associated with broadly neutralizing influenza antibodies.
Some antibodies isolated from individuals with no known H5 exposure neutralized the virus at potencies comparable to established laboratory reference antibodies.
Put simply, the body already has a built-in playbook for H5N1, even in people who have never encountered the virus.
Antibodies Protected Against Lethal Infection in Animal Tests
To test whether these antibodies were biologically meaningful, the researchers said they administered selected antibodies to mice before exposing them to a lethal dose of the cattle-derived H5N1 virus.
All mice that received H5-specific antibodies survived the infection, while control animals that received unrelated antibodies died or met humane endpoints.
Protection occurred even though the antibody levels were similar to those detected in unexposed humans.
The authors conclude that antibodies derived from H5N1-naïve individuals were sufficient to prevent fatal disease in vivo.
Contrast With COVID-19 Pre-Pandemic Immunity
In the discussion section, the researchers explicitly contrast their findings with the situation prior to the COVID-19 pandemic, writing:
“This is in contrast to the lack of cross-neutralizing antibodies for SARS-CoV-2 before the emergence of the COVID-19 pandemic.”
The comparison underscores that, unlike what is said of SARS-CoV-2, H5N1 does not appear to be entering the human population as an entirely immunologically novel virus.
What the Study Does—and Does Not—Claim
The researchers claim that their findings do not assess the risk of human-to-human transmission and do not predict future outbreak dynamics.
The study also does not claim that existing antibodies would prevent infection altogether.
However, the data directly contradicts the premise that humans lack any meaningful baseline immune response to emerging H5N1 strains.
As the authors summarize, pre-existing humoral immunity to the cattle-linked H5N1 virus is detectable in individuals considered unexposed.
Bottom Line
The findings show that H5N1 is not entering the human population as an immunological blank slate: most people already carry antibodies and immune memory capable of recognizing and neutralizing the virus, even without prior exposure.
This directly undercuts pandemic narratives that portray H5N1 as a wholly novel, population-wide threat requiring emergency gain-of-function research or mass vaccine programs to create immunity from scratch.
While the study does not address transmission dynamics, it clearly demonstrates that baseline human immunity to H5N1 already exists—raising questions about whether current levels of alarm, experimentation, and preemptive intervention are scientifically justified.
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities reaching 300,000+ monthly viewers, contact us by clicking below.
You can't keep the fear level up to push injections if the public knew the truth!
The easiest way to destroy that broad natural immunity is to inject a specific antigen (or the message to make it) in a product called a vaccine, targeting the immune system to that specific antigen.